NCT03571009 is a NA clinical trial of utilization of PAAS in Pain, sponsored by Ji Hyeon Ju.

Who is sponsoring NCT03571009?

NCT03571009 is sponsored by Ji Hyeon Ju.

What drugs are being tested in NCT03571009?

Interventions in NCT03571009: utilization of PAAS.

What condition does NCT03571009 study?

NCT03571009 studies Pain, Fibromyalgia.

Is NCT03571009 still recruiting?

NCT03571009 is currently completed. Last updated 27 June 2018.

Last reviewed 2018-06-27 · How we verify

NCT03571009

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Real-time Pain Monitoring in Fibromyalgia Patients

Completed NA Last updated 27 June 2018

What this trial tests

NA trial testing utilization of PAAS in Pain in 25 participants. Completed in 21 September 2017.

Timeline

22 December 2015

Primary endpoint
30 November 2016

21 September 2017

Quick facts

Lead sponsor	Ji Hyeon Ju
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	supportive care
Enrollment	25
Start date	22 December 2015
Primary completion	30 November 2016
Estimated completion	21 September 2017

Drugs / interventions tested

utilization of PAAS

Conditions studied

Pain — all drugs for Pain →
Fibromyalgia — all drugs for Fibromyalgia →

Sponsor

Ji Hyeon Ju

Who can join

19 and older, any sex, with Pain or Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine whether the pain of fibromyalgia patients can be reduced with utilization of real-time pain monitoring system (PAAS). In this pilot study, adult fibromyalgia patients were randomly assigned to use or to not use PAAS. Changes in the visual analogue scale (VAS) were examined by rheumatologists at baseline and after three months, and correlations between conventional pain VAS or PAAS VAS and clinical parameters (patient global assessment, physician global assessment, fibromyalgia impact questionnaire) were investigated. We also examined if the utilization of PAAS can affect health related quality of life and depression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03571009 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ji Hyeon Ju
Last refreshed: 27 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03571009.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing